V0034CR01B

DRUG2 trials

Sponsors

Orfagen, Pierre Fabre Medicament

Conditions

Atopic DermatitisUremic Xerosis

Phase 3

Long-term Efficacy and Safety of V0034 CR 01B Cream in Patients With Moderate-to-severe Uremic Xerosis

CompletedNCT01084148

OrfagenUremic Xerosis

Start: 2007-01-31End: 2009-03-31Updated: 2017-12-20

Efficacy Emollient on Xerosis in Children With Atopic Dermatitis

CompletedNCT01467362

Pierre Fabre MedicamentAtopic Dermatitis

Start: 2011-11-30End: 2012-05-31Updated: 2013-02-21

Related Papers

Long-Term Efficacy and Tolerability of an Emollient Containing Glycerol and Paraffin for Moderate-to-Severe Uremic Xerosis: A Randomized Phase 3 Study.

2024-10-182 citations